Final results from a real world evidence study on the treatment of migraine patients with Erenumab In GERMANY (SPECTRE)

被引：0
|
作者：
Gaul, C. [1 ]
Koch, M. [2 ]
Baufeld, C. [3 ]
机构：
[1] Headache Ctr, Frankfurt, Germany
[2] Novartis Pharma AG, Basel, Switzerland
[3] Novartis Pharma GmbH, Nurnberg, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR-036
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [1] Final results of the SPECTRE study: real-world data giving an insight into the treatment of migraine patients with erenumab in Germany
    Gaul, Charly
    Koch, Mirja
    Weiss, Cordula
    NEUROLOGY, 2023, 100 (17)
  • [2] Real-World Experience of Erenumab in Patients with Migraine in Germany: The SPECTRE Study
    Gaul, Charly
    Gendolla, Astrid
    Holle, Dagny
    Goebel, Hartmut
    Koch, Mirja
    Baufeld, Caroline
    Weiss, Cordula
    PAIN AND THERAPY, 2024, 13 (06) : 1659 - 1678
  • [3] Real-world data on erenumab interruption in migraine patients in Germany: the SPECTRE study
    Gaul, Charly
    Goebel, Hartmut
    Koch, Mirja
    Weiss, Cordula
    CEPHALALGIA, 2023, 43 (1supp) : 232 - 233
  • [4] Characterisation of prescription patterns in episodic and chronic migraine patients starting treatment in a real life setting with erenumab in Germany (SPECTRE) - A real world evidence study
    Gaul, C.
    Koch, M.
    Baufeld, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 154 - 154
  • [5] BASELINE DATA OF A REAL-WORLD-EVIDENCE-STUDY CHARACTERIZING PRESCRIPTION PATTERNS IN EPISODIC AND CHRONIC MIGRAINE PATIENTS STARTING TREATMENT WITH ERENUMAB IN GERMANY (SPECTRE)
    Gaul, Charly
    Koch, Mirja
    Baufeld, Caroline
    CEPHALALGIA, 2020, 40 : 67 - 67
  • [6] Erenumab for Migraine Treatment - First Real World Data from Germany
    Naegel, Steffen
    Scheffler, Armin
    Wurthmann, Sebastian F.
    Holle, Dagny
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 409 - 409
  • [7] Erenumab discontinuation in migraine patients: final results of the APOLLON study
    Goebel, H.
    Koch, M.
    Weiss, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 483 - 483
  • [8] Characterisation of patient and treatment profiles of migraine patients treated with erenumab in routine clinicl practice: Interim results from the SPECTRE study
    Gal, C.
    Koch, M.
    Baufeld, C.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 166 - 166
  • [9] Characterisation of patient and treatment profiles of migraine patients treated with erenumab in routine clinicl practice: Interim results from the SPECTRE study
    Gal, C.
    Koch, M.
    Baufeld, C.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 112 - 112
  • [10] Impact of a reimbursement policy change on treatment with erenumab in migraine - a real-world experience from Germany
    Hong, Ja Bin
    Lange, Kristin Sophie
    Fitzek, Mira
    Overeem, Lucas Hendrik
    Triller, Paul
    Siebert, Anke
    Reuter, Uwe
    Raffaelli, Bianca
    JOURNAL OF HEADACHE AND PAIN, 2023, 24 (01):
12345